XML 23 R79.htm IDEA: XBRL DOCUMENT v2.4.1.9

Business Segment Information - Summary of Net Margin, Defined as Gross Profit Less Sales and Marketing Expenses from Continuing Operations by SBU Reporting Segment (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended								6 Months Ended	12 Months Ended
	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Sales Information [Line Items]
Total net margin										$ 115,231ofix_ContributionsMargin	$ 160,692ofix_ContributionsMargin	$ 153,948ofix_ContributionsMargin
General and administrative										64,830us-gaap_GeneralAndAdministrativeExpense	53,650us-gaap_GeneralAndAdministrativeExpense	64,785us-gaap_GeneralAndAdministrativeExpense
Research and development										26,768us-gaap_ResearchAndDevelopmentExpense	28,577us-gaap_ResearchAndDevelopmentExpense	22,861us-gaap_ResearchAndDevelopmentExpense
Amortization of intangible assets										2,687us-gaap_AmortizationOfIntangibleAssets	2,298us-gaap_AmortizationOfIntangibleAssets	2,550us-gaap_AmortizationOfIntangibleAssets
Costs related to the accounting review and restatement										12,945ofix_AccountingReviewAndRestatementCosts
Impairment of goodwill									19,193us-gaap_GoodwillImpairmentLoss	19,193us-gaap_GoodwillImpairmentLoss
Charges related to U.S. Government resolutions											1,295us-gaap_GainLossRelatedToLitigationSettlement	57,141us-gaap_GainLossRelatedToLitigationSettlement
Operating (loss) income	(10,079)us-gaap_OperatingIncomeLoss	(14,101)us-gaap_OperatingIncomeLoss	6,920us-gaap_OperatingIncomeLoss	6,068us-gaap_OperatingIncomeLoss	26,518us-gaap_OperatingIncomeLoss	16,943us-gaap_OperatingIncomeLoss	16,622us-gaap_OperatingIncomeLoss	14,789us-gaap_OperatingIncomeLoss		(11,192)us-gaap_OperatingIncomeLoss	74,872us-gaap_OperatingIncomeLoss	6,611us-gaap_OperatingIncomeLoss
BioStim [Member]
Sales Information [Line Items]
Impairment of goodwill
Biologics [Member]
Sales Information [Line Items]
Impairment of goodwill
Extremity Fixation [Member]
Sales Information [Line Items]
Impairment of goodwill									9,825us-gaap_GoodwillImpairmentLoss / us-gaap_StatementBusinessSegmentsAxis = ofix_ExtremityFixationMember
Spine Fixation [Member]
Sales Information [Line Items]
Impairment of goodwill									9,368us-gaap_GoodwillImpairmentLoss / us-gaap_StatementBusinessSegmentsAxis = ofix_SpineFixationMember
Operating Segments [Member] | BioStim [Member]
Sales Information [Line Items]
Total net margin										63,847ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = ofix_BiostimMember	88,788ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = ofix_BiostimMember	92,860ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = ofix_BiostimMember
Operating Segments [Member] | Biologics [Member]
Sales Information [Line Items]
Total net margin										24,794ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = ofix_BiologicsMember	23,589ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = ofix_BiologicsMember	18,978ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = ofix_BiologicsMember
Operating Segments [Member] | Extremity Fixation [Member]
Sales Information [Line Items]
Total net margin										23,704ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = ofix_ExtremityFixationMember	34,554ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = ofix_ExtremityFixationMember	30,773ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = ofix_ExtremityFixationMember
Operating Segments [Member] | Spine Fixation [Member]
Sales Information [Line Items]
Total net margin										4,329ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = ofix_SpineFixationMember	15,256ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = ofix_SpineFixationMember	13,037ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = ofix_SpineFixationMember
Corporate, Non-Segment [Member]
Sales Information [Line Items]
Total net margin										1,443ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_CorporateNonSegmentMember	1,495ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_CorporateNonSegmentMember	1,700ofix_ContributionsMargin / us-gaap_ConsolidationItemsAxis = us-gaap_CorporateNonSegmentMember
Material Reconciling Items [Member]
Sales Information [Line Items]
General and administrative										64,830us-gaap_GeneralAndAdministrativeExpense / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember	53,650us-gaap_GeneralAndAdministrativeExpense / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember	64,785us-gaap_GeneralAndAdministrativeExpense / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember
Research and development										26,768us-gaap_ResearchAndDevelopmentExpense / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember	28,577us-gaap_ResearchAndDevelopmentExpense / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember	22,861us-gaap_ResearchAndDevelopmentExpense / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember
Amortization of intangible assets										2,687us-gaap_AmortizationOfIntangibleAssets / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember	2,298us-gaap_AmortizationOfIntangibleAssets / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember	2,550us-gaap_AmortizationOfIntangibleAssets / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember
Costs related to the accounting review and restatement										12,945ofix_AccountingReviewAndRestatementCosts / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember
Impairment of goodwill										19,193us-gaap_GoodwillImpairmentLoss / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember
Charges related to U.S. Government resolutions											1,295us-gaap_GainLossRelatedToLitigationSettlement / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember	57,141us-gaap_GainLossRelatedToLitigationSettlement / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember
Operating (loss) income										$ (11,192)us-gaap_OperatingIncomeLoss / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember	$ 74,872us-gaap_OperatingIncomeLoss / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember	$ 6,611us-gaap_OperatingIncomeLoss / us-gaap_ConsolidationItemsAxis = us-gaap_MaterialReconcilingItemsMember

X

- Definition

Accounting review and restatement costs.

+ References

No definition available.

+ Details

Name:	ofix_AccountingReviewAndRestatementCosts
Namespace Prefix:	ofix_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Contributions Margin

+ References

No definition available.

+ Details

Name:	ofix_ContributionsMargin
Namespace Prefix:	ofix_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	ofix_SalesInformationLineItems
Namespace Prefix:	ofix_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274



Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name:	us-gaap_AmortizationOfIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

+ Details

Name:	us-gaap_GainLossRelatedToLitigationSettlement
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name:	us-gaap_GeneralAndAdministrativeExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13854-109267



Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266



Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

+ Details

Name:	us-gaap_GoodwillImpairmentLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name:	us-gaap_OperatingIncomeLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=ofix_BiologicsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=ofix_BiostimMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=ofix_ExtremityFixationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=ofix_SpineFixationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: